XPO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
XPO Inc is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock has strong analyst support, hedge fund buying momentum, and a favorable options sentiment. While recent financial performance shows a decline in net income and EPS, the company's revenue growth and gross margin improvement indicate operational resilience. The technical indicators are neutral, but the stock's long-term growth potential and positive catalysts outweigh short-term concerns.
The MACD histogram is negative (-3.152), indicating bearish momentum, but it is contracting, which could signal a potential reversal. RSI is neutral at 40.192, and moving averages are converging, suggesting no strong trend. The stock is trading near its pivot level of 188.976, with key resistance at 197.812 and support at 180.141.
Hedge funds are significantly increasing their positions in XPO, with a 226.61% increase in buying activity last quarter.
Analysts have consistently raised price targets, with targets now ranging from $201 to $250, reflecting confidence in the company's growth potential.
The transportation sector is benefiting from a recovery in the freight cycle, which could drive further upside for XPO.
Recent financial performance shows a decline in net income (-21.33% YoY) and EPS (-19.35% YoY), which could be a concern for some investors.
Technical indicators are neutral, with no clear bullish signals in the short term.
Susquehanna downgraded the stock to Neutral, citing valuation concerns and suggesting the stock may have already priced in a cyclical recovery.
In Q4 2025, XPO reported revenue growth of 4.63% YoY to $2.011 billion, indicating strong top-line performance. However, net income dropped by 21.33% YoY to $59 million, and EPS decreased by 19.35% YoY to $0.50, reflecting margin pressures. Gross margin improved slightly to 53.61%, up 0.71% YoY, showcasing operational efficiency.
Analysts are overwhelmingly bullish on XPO, with multiple firms raising price targets recently. JPMorgan, Oppenheimer, Benchmark, BofA, and Jefferies have all increased their targets, with the highest target now at $250. Most analysts maintain Buy or Outperform ratings, citing strong operational performance, cost efficiency initiatives, and favorable sector dynamics. However, Susquehanna downgraded the stock to Neutral, citing valuation concerns.
